Hu Y, Schnabl B, Starkel P
Cells. 2025; 14(3).
PMID: 39936998
PMC: 11816606.
DOI: 10.3390/cells14030207.
He X, Li G, Huang L, Shi H, Zhong S, Zhao S
MedComm (2020). 2025; 6(1):e70035.
PMID: 39760110
PMC: 11695212.
DOI: 10.1002/mco2.70035.
Gupta D, Wiklander O, Wood M, El-Andaloussi S
Extracell Vesicles Circ Nucl Acids. 2024; 4(2):170-190.
PMID: 39697988
PMC: 11648525.
DOI: 10.20517/evcna.2023.12.
Beadell B, Yamauchi J, Wong-Beringer A
J Antimicrob Chemother. 2024; 79(10):2471-2478.
PMID: 39073778
PMC: 11441993.
DOI: 10.1093/jac/dkae241.
Kooshki S, Mirzaeian L, Malakhond M, Goudarzi I, Taghi Ghorbanian M
Biol Futur. 2024; 75(4):425-435.
PMID: 38937316
DOI: 10.1007/s42977-024-00226-2.
Research progress and application of liver organoids for disease modeling and regenerative therapy.
Hu Y, Geng Q, Wang L, Wang Y, Huang C, Fan Z
J Mol Med (Berl). 2024; 102(7):859-874.
PMID: 38802517
PMC: 11213763.
DOI: 10.1007/s00109-024-02455-3.
Current Evidence and Perspectives of Cluster of Differentiation 44 in the Liver's Physiology and Pathology.
Han J, Lee C, Jung Y
Int J Mol Sci. 2024; 25(9).
PMID: 38731968
PMC: 11084344.
DOI: 10.3390/ijms25094749.
Multiscale transport and 4D time-lapse imaging in precision-cut liver slices (PCLS).
Azam I, Benson J
PeerJ. 2024; 12:e16994.
PMID: 38426134
PMC: 10903333.
DOI: 10.7717/peerj.16994.
Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease.
Blake M, Steer C
Hepat Med. 2024; 16:11-29.
PMID: 38379783
PMC: 10878318.
DOI: 10.2147/HMER.S440697.
Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration.
Allu I, Kumar Sahi A, Koppadi M, Gundu S, Sionkowska A
J Funct Biomater. 2023; 14(10).
PMID: 37888183
PMC: 10607724.
DOI: 10.3390/jfb14100518.
Three Dimensional Bioprinting for Hepatic Tissue Engineering: From In Vitro Models to Clinical Applications.
Kasturi M, Mathur V, Gadre M, Srinivasan V, Vasanthan K
Tissue Eng Regen Med. 2023; 21(1):21-52.
PMID: 37882981
PMC: 10764711.
DOI: 10.1007/s13770-023-00576-3.
Modulation of the immune response by the host defense peptide IDR-1002 in chicken hepatic cell culture.
Sebok C, Traj P, Mackei M, Marton R, Voroshazi J, Kemeny A
Sci Rep. 2023; 13(1):14530.
PMID: 37666888
PMC: 10477227.
DOI: 10.1038/s41598-023-41707-z.
Ginsenoside Rg3-enriched Korean Red Ginseng extract attenuates Non-Alcoholic Fatty Liver Disease by way of suppressed VCAM-1 expression in liver sinusoidal endothelium.
Lee S, Baek S, Lee Y, Kim T, Yim J, Son J
J Ginseng Res. 2023; 47(3):429-439.
PMID: 37252282
PMC: 10214299.
DOI: 10.1016/j.jgr.2022.10.005.
Luteolin: A Phytochemical to Mitigate Typhimurium Flagellin-Induced Inflammation in a Chicken In Vitro Hepatic Model.
Traj P, Sebok C, Mackei M, Kemeny A, Farkas O, Kakonyi A
Animals (Basel). 2023; 13(8).
PMID: 37106972
PMC: 10135145.
DOI: 10.3390/ani13081410.
The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl-Induced Liver Fibrosis in Rats.
Ghobrial D, El-Nikhely N, Sheta E, Ragab H, Rostom S, Saeed H
Antioxidants (Basel). 2023; 12(3).
PMID: 36978885
PMC: 10045301.
DOI: 10.3390/antiox12030637.
Physiomimetic In Vitro Human Models for Viral Infection in the Liver.
McDuffie D, Barr D, Helm M, Baumert T, Agarwal A, Thomas E
Semin Liver Dis. 2022; 43(1):31-49.
PMID: 36402129
PMC: 10005888.
DOI: 10.1055/a-1981-5944.
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma.
Yoon J, Lee C
Exp Mol Med. 2022; 54(11):1799-1813.
PMID: 36380016
PMC: 9722691.
DOI: 10.1038/s12276-022-00883-0.
Evolution of Electrospinning in Liver Tissue Engineering.
Vasudevan A, Tripathi D, Sundarrajan S, Venugopal J, Ramakrishna S, Kaur S
Biomimetics (Basel). 2022; 7(4).
PMID: 36278706
PMC: 9589992.
DOI: 10.3390/biomimetics7040149.
Physiologically relevant microsystems to study viral infection in the human liver.
McDuffie D, Barr D, Agarwal A, Thomas E
Front Microbiol. 2022; 13():999366.
PMID: 36246284
PMC: 9555087.
DOI: 10.3389/fmicb.2022.999366.
Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis.
Zhang Y, Xiao N, Liu Q, Nie Y, Zhu X
Dis Markers. 2022; 2022:7881478.
PMID: 35664435
PMC: 9159836.
DOI: 10.1155/2022/7881478.